Loading…
Systematic review of pre-clinical chronic myeloid leukaemia
Background Studies of a provisional entity pre-clinical chronic myeloid leukaemia (CML), which precedes chronic phase (CP) without leucocytosis or blood/marrow feature of CML CP, has been increasing. Objective To perform a systematic review of pre-clinical CML and analysis the data relevant to disea...
Saved in:
| Published in: | International journal of hematology 2018-11, Vol.108 (5), p.465-484 |
|---|---|
| Main Authors: | , , , , |
| Format: | Article |
| Language: | English |
| Subjects: | |
| Citations: | Items that this one cites Items that cite this one |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| cited_by | cdi_FETCH-LOGICAL-c396t-3b815beb89b29b6d84ffe61efd18f5b5a59f6eecea005723091bff887ef3b92f3 |
|---|---|
| cites | cdi_FETCH-LOGICAL-c396t-3b815beb89b29b6d84ffe61efd18f5b5a59f6eecea005723091bff887ef3b92f3 |
| container_end_page | 484 |
| container_issue | 5 |
| container_start_page | 465 |
| container_title | International journal of hematology |
| container_volume | 108 |
| creator | Kuan, Jew Win Su, Anselm Ting Leong, Chooi Fun Osato, Motomi Sashida, Goro |
| description | Background
Studies of a provisional entity pre-clinical chronic myeloid leukaemia (CML), which precedes chronic phase (CP) without leucocytosis or blood/marrow feature of CML CP, has been increasing.
Objective
To perform a systematic review of pre-clinical CML and analysis the data relevant to disease progression to CML CP.
Method
We performed a literature search on 16 July 2017 using EBSCOhost Research Databases interface and Western Pacific Region Index Medicus. Two authors selected the studies, extracted the data and evaluated the quality of studies using an 8-item tool, independently. The outcomes were percentage of Philadelphia chromosome in the number of metaphases examined (Ph%), correlation between Ph% and blood count and time progress to CML.
Result
Our initial search returned 4770 studies. A total of 10 studies with a total 17 subjects were included. The lowest Ph%, which eventually progresses to CML, was 10%. Absolute basophil count seemed to correlate better with Ph% compared to total white cell and absolute eosinophil count. The time from the first documented pre-clinical CML to CML ranged from 12 to 48 months. The overall quality of the included studies was average.
Conclusion
This is the first systematic review on pre-clinical CML. This entity requires additional large-scale studies. |
| doi_str_mv | 10.1007/s12185-018-2528-x |
| format | article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2105055135</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2105055135</sourcerecordid><originalsourceid>FETCH-LOGICAL-c396t-3b815beb89b29b6d84ffe61efd18f5b5a59f6eecea005723091bff887ef3b92f3</originalsourceid><addsrcrecordid>eNp1kMtKAzEUhoMoWi8P4EYG3LiJ5iTNJMGVFG8guFDXIZme6NSZTk062r69KfUCgqscyPf_5_ARcgjsFBhTZwk4aEkZaMol13SxQQagS0mFUsNNMmCGSyoVsB2ym9KEMVBsqLbJjmA5yFU5IOcPyzTH1s3rqoj4XuNH0YViFpFWTT2tK9cU1Uvs8lS0S2y6elw02L86bGu3T7aCaxIefL175Onq8nF0Q-_ur29HF3e0EqacU-E1SI9eG8-NL8d6GAKWgGEMOkgvnTShRKzQMSYVF8yAD0FrhUF4w4PYIyfr3lns3npMc9vWqcKmcVPs-mQ5MMmkBCEzevwHnXR9nObrVpQwBriATMGaqmKXUsRgZ7FuXVxaYHZl1q7N2mzWrszaRc4cfTX3vsXxT-JbZQb4Gkj5a_qM8Xf1_62fbiqD1w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2103991231</pqid></control><display><type>article</type><title>Systematic review of pre-clinical chronic myeloid leukaemia</title><source>Springer Link</source><creator>Kuan, Jew Win ; Su, Anselm Ting ; Leong, Chooi Fun ; Osato, Motomi ; Sashida, Goro</creator><creatorcontrib>Kuan, Jew Win ; Su, Anselm Ting ; Leong, Chooi Fun ; Osato, Motomi ; Sashida, Goro</creatorcontrib><description>Background
Studies of a provisional entity pre-clinical chronic myeloid leukaemia (CML), which precedes chronic phase (CP) without leucocytosis or blood/marrow feature of CML CP, has been increasing.
Objective
To perform a systematic review of pre-clinical CML and analysis the data relevant to disease progression to CML CP.
Method
We performed a literature search on 16 July 2017 using EBSCOhost Research Databases interface and Western Pacific Region Index Medicus. Two authors selected the studies, extracted the data and evaluated the quality of studies using an 8-item tool, independently. The outcomes were percentage of Philadelphia chromosome in the number of metaphases examined (Ph%), correlation between Ph% and blood count and time progress to CML.
Result
Our initial search returned 4770 studies. A total of 10 studies with a total 17 subjects were included. The lowest Ph%, which eventually progresses to CML, was 10%. Absolute basophil count seemed to correlate better with Ph% compared to total white cell and absolute eosinophil count. The time from the first documented pre-clinical CML to CML ranged from 12 to 48 months. The overall quality of the included studies was average.
Conclusion
This is the first systematic review on pre-clinical CML. This entity requires additional large-scale studies.</description><identifier>ISSN: 0925-5710</identifier><identifier>EISSN: 1865-3774</identifier><identifier>DOI: 10.1007/s12185-018-2528-x</identifier><identifier>PMID: 30218276</identifier><language>eng</language><publisher>Tokyo: Springer Japan</publisher><subject>Blood ; Bone Marrow - pathology ; Chronic myeloid leukemia ; Data processing ; Disease Progression ; Hematology ; Humans ; Leukemia ; Leukemia, Myelogenous, Chronic, BCR-ABL Positive - diagnosis ; Leukemia, Myelogenous, Chronic, BCR-ABL Positive - genetics ; Leukemia, Myelogenous, Chronic, BCR-ABL Positive - therapy ; Leukemia, Myeloid, Chronic-Phase ; Leukocytes (eosinophilic) ; Leukocytosis - pathology ; Medicine ; Medicine & Public Health ; Oncology ; Philadelphia chromosome ; Review Article ; Reviews ; Systematic review ; Treatment Outcome</subject><ispartof>International journal of hematology, 2018-11, Vol.108 (5), p.465-484</ispartof><rights>The Japanese Society of Hematology 2018</rights><rights>International Journal of Hematology is a copyright of Springer, (2018). All Rights Reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c396t-3b815beb89b29b6d84ffe61efd18f5b5a59f6eecea005723091bff887ef3b92f3</citedby><cites>FETCH-LOGICAL-c396t-3b815beb89b29b6d84ffe61efd18f5b5a59f6eecea005723091bff887ef3b92f3</cites><orcidid>0000-0003-1686-5570</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30218276$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kuan, Jew Win</creatorcontrib><creatorcontrib>Su, Anselm Ting</creatorcontrib><creatorcontrib>Leong, Chooi Fun</creatorcontrib><creatorcontrib>Osato, Motomi</creatorcontrib><creatorcontrib>Sashida, Goro</creatorcontrib><title>Systematic review of pre-clinical chronic myeloid leukaemia</title><title>International journal of hematology</title><addtitle>Int J Hematol</addtitle><addtitle>Int J Hematol</addtitle><description>Background
Studies of a provisional entity pre-clinical chronic myeloid leukaemia (CML), which precedes chronic phase (CP) without leucocytosis or blood/marrow feature of CML CP, has been increasing.
Objective
To perform a systematic review of pre-clinical CML and analysis the data relevant to disease progression to CML CP.
Method
We performed a literature search on 16 July 2017 using EBSCOhost Research Databases interface and Western Pacific Region Index Medicus. Two authors selected the studies, extracted the data and evaluated the quality of studies using an 8-item tool, independently. The outcomes were percentage of Philadelphia chromosome in the number of metaphases examined (Ph%), correlation between Ph% and blood count and time progress to CML.
Result
Our initial search returned 4770 studies. A total of 10 studies with a total 17 subjects were included. The lowest Ph%, which eventually progresses to CML, was 10%. Absolute basophil count seemed to correlate better with Ph% compared to total white cell and absolute eosinophil count. The time from the first documented pre-clinical CML to CML ranged from 12 to 48 months. The overall quality of the included studies was average.
Conclusion
This is the first systematic review on pre-clinical CML. This entity requires additional large-scale studies.</description><subject>Blood</subject><subject>Bone Marrow - pathology</subject><subject>Chronic myeloid leukemia</subject><subject>Data processing</subject><subject>Disease Progression</subject><subject>Hematology</subject><subject>Humans</subject><subject>Leukemia</subject><subject>Leukemia, Myelogenous, Chronic, BCR-ABL Positive - diagnosis</subject><subject>Leukemia, Myelogenous, Chronic, BCR-ABL Positive - genetics</subject><subject>Leukemia, Myelogenous, Chronic, BCR-ABL Positive - therapy</subject><subject>Leukemia, Myeloid, Chronic-Phase</subject><subject>Leukocytes (eosinophilic)</subject><subject>Leukocytosis - pathology</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Oncology</subject><subject>Philadelphia chromosome</subject><subject>Review Article</subject><subject>Reviews</subject><subject>Systematic review</subject><subject>Treatment Outcome</subject><issn>0925-5710</issn><issn>1865-3774</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNp1kMtKAzEUhoMoWi8P4EYG3LiJ5iTNJMGVFG8guFDXIZme6NSZTk062r69KfUCgqscyPf_5_ARcgjsFBhTZwk4aEkZaMol13SxQQagS0mFUsNNMmCGSyoVsB2ym9KEMVBsqLbJjmA5yFU5IOcPyzTH1s3rqoj4XuNH0YViFpFWTT2tK9cU1Uvs8lS0S2y6elw02L86bGu3T7aCaxIefL175Onq8nF0Q-_ur29HF3e0EqacU-E1SI9eG8-NL8d6GAKWgGEMOkgvnTShRKzQMSYVF8yAD0FrhUF4w4PYIyfr3lns3npMc9vWqcKmcVPs-mQ5MMmkBCEzevwHnXR9nObrVpQwBriATMGaqmKXUsRgZ7FuXVxaYHZl1q7N2mzWrszaRc4cfTX3vsXxT-JbZQb4Gkj5a_qM8Xf1_62fbiqD1w</recordid><startdate>20181101</startdate><enddate>20181101</enddate><creator>Kuan, Jew Win</creator><creator>Su, Anselm Ting</creator><creator>Leong, Chooi Fun</creator><creator>Osato, Motomi</creator><creator>Sashida, Goro</creator><general>Springer Japan</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7T5</scope><scope>7T7</scope><scope>7TM</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-1686-5570</orcidid></search><sort><creationdate>20181101</creationdate><title>Systematic review of pre-clinical chronic myeloid leukaemia</title><author>Kuan, Jew Win ; Su, Anselm Ting ; Leong, Chooi Fun ; Osato, Motomi ; Sashida, Goro</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c396t-3b815beb89b29b6d84ffe61efd18f5b5a59f6eecea005723091bff887ef3b92f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Blood</topic><topic>Bone Marrow - pathology</topic><topic>Chronic myeloid leukemia</topic><topic>Data processing</topic><topic>Disease Progression</topic><topic>Hematology</topic><topic>Humans</topic><topic>Leukemia</topic><topic>Leukemia, Myelogenous, Chronic, BCR-ABL Positive - diagnosis</topic><topic>Leukemia, Myelogenous, Chronic, BCR-ABL Positive - genetics</topic><topic>Leukemia, Myelogenous, Chronic, BCR-ABL Positive - therapy</topic><topic>Leukemia, Myeloid, Chronic-Phase</topic><topic>Leukocytes (eosinophilic)</topic><topic>Leukocytosis - pathology</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Oncology</topic><topic>Philadelphia chromosome</topic><topic>Review Article</topic><topic>Reviews</topic><topic>Systematic review</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kuan, Jew Win</creatorcontrib><creatorcontrib>Su, Anselm Ting</creatorcontrib><creatorcontrib>Leong, Chooi Fun</creatorcontrib><creatorcontrib>Osato, Motomi</creatorcontrib><creatorcontrib>Sashida, Goro</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Nursing & Allied Health Database</collection><collection>Immunology Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Nucleic Acids Abstracts</collection><collection>ProQuest Health and Medical</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of hematology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kuan, Jew Win</au><au>Su, Anselm Ting</au><au>Leong, Chooi Fun</au><au>Osato, Motomi</au><au>Sashida, Goro</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Systematic review of pre-clinical chronic myeloid leukaemia</atitle><jtitle>International journal of hematology</jtitle><stitle>Int J Hematol</stitle><addtitle>Int J Hematol</addtitle><date>2018-11-01</date><risdate>2018</risdate><volume>108</volume><issue>5</issue><spage>465</spage><epage>484</epage><pages>465-484</pages><issn>0925-5710</issn><eissn>1865-3774</eissn><abstract>Background
Studies of a provisional entity pre-clinical chronic myeloid leukaemia (CML), which precedes chronic phase (CP) without leucocytosis or blood/marrow feature of CML CP, has been increasing.
Objective
To perform a systematic review of pre-clinical CML and analysis the data relevant to disease progression to CML CP.
Method
We performed a literature search on 16 July 2017 using EBSCOhost Research Databases interface and Western Pacific Region Index Medicus. Two authors selected the studies, extracted the data and evaluated the quality of studies using an 8-item tool, independently. The outcomes were percentage of Philadelphia chromosome in the number of metaphases examined (Ph%), correlation between Ph% and blood count and time progress to CML.
Result
Our initial search returned 4770 studies. A total of 10 studies with a total 17 subjects were included. The lowest Ph%, which eventually progresses to CML, was 10%. Absolute basophil count seemed to correlate better with Ph% compared to total white cell and absolute eosinophil count. The time from the first documented pre-clinical CML to CML ranged from 12 to 48 months. The overall quality of the included studies was average.
Conclusion
This is the first systematic review on pre-clinical CML. This entity requires additional large-scale studies.</abstract><cop>Tokyo</cop><pub>Springer Japan</pub><pmid>30218276</pmid><doi>10.1007/s12185-018-2528-x</doi><tpages>20</tpages><orcidid>https://orcid.org/0000-0003-1686-5570</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0925-5710 |
| ispartof | International journal of hematology, 2018-11, Vol.108 (5), p.465-484 |
| issn | 0925-5710 1865-3774 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2105055135 |
| source | Springer Link |
| subjects | Blood Bone Marrow - pathology Chronic myeloid leukemia Data processing Disease Progression Hematology Humans Leukemia Leukemia, Myelogenous, Chronic, BCR-ABL Positive - diagnosis Leukemia, Myelogenous, Chronic, BCR-ABL Positive - genetics Leukemia, Myelogenous, Chronic, BCR-ABL Positive - therapy Leukemia, Myeloid, Chronic-Phase Leukocytes (eosinophilic) Leukocytosis - pathology Medicine Medicine & Public Health Oncology Philadelphia chromosome Review Article Reviews Systematic review Treatment Outcome |
| title | Systematic review of pre-clinical chronic myeloid leukaemia |
| url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T11%3A21%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Systematic%20review%20of%20pre-clinical%20chronic%20myeloid%20leukaemia&rft.jtitle=International%20journal%20of%20hematology&rft.au=Kuan,%20Jew%20Win&rft.date=2018-11-01&rft.volume=108&rft.issue=5&rft.spage=465&rft.epage=484&rft.pages=465-484&rft.issn=0925-5710&rft.eissn=1865-3774&rft_id=info:doi/10.1007/s12185-018-2528-x&rft_dat=%3Cproquest_cross%3E2105055135%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c396t-3b815beb89b29b6d84ffe61efd18f5b5a59f6eecea005723091bff887ef3b92f3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2103991231&rft_id=info:pmid/30218276&rfr_iscdi=true |